Literature DB >> 31223104

Clozapine-induced interstitial nephritis in a patient with schizoaffective disorder in the forensic setting: a case report and review of the literature.

C McLoughlin1, C Cooney2, R Mullaney2.   

Abstract

We present a rare case of Acute Interstitial Nephritis (AIN) that occurred following a re-trial of clozapine in a 56-year-old lady with schizoaffective disorder. On initial trial of clozapine, this patient felt generally unwell with respiratory symptoms. Her inflammatory markers were raised and her renal function showed a mild, transient deterioration which normalised on the day of cessation of clozapine. Two years later, clozapine was re-trialled due the refractory nature of her psychiatric symptoms. She subsequently developed renal failure and AIN was confirmed by renal biopsy. Renal function improved after cessation of clozapine; however, she never fully regained normal renal function.

Entities:  

Keywords:  Clozapine/adverse effects; interstitial nephritis; renal failure

Mesh:

Substances:

Year:  2019        PMID: 31223104     DOI: 10.1017/ipm.2019.24

Source DB:  PubMed          Journal:  Ir J Psychol Med        ISSN: 0790-9667


  3 in total

1.  The Effects of Use of Long-Term Second-Generation Antipsychotics on Liver and Kidney Function: A Prospective Study.

Authors:  Evangelia Papatriantafyllou; Dimitris Efthymiou; Maria Markopoulou; Efthymia-Maria Sakellariou; Emilia Vassilopoulou
Journal:  Diseases       Date:  2022-07-22

2.  Acute Interstitial Nephritis Induced by Clozapine.

Authors:  Praveena Vantipalli; Sasmit Roy; Narayana M Koduri; Venu Madhav Konala; Amarinder Singh Garcha; Srikanth Kunaparaju; Raul Ayala; Samanvitha Sai Yarram; Sreedhar Adapa
Journal:  J Med Cases       Date:  2022-06-16

3.  Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study.

Authors:  Mikkel Højlund; Lars Christian Lund; Jonas Leander Emming Herping; Maija Bruun Haastrup; Per Damkier; Daniel Pilsgaard Henriksen
Journal:  BMJ Open       Date:  2020-08-11       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.